Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo

Ikuhiko Nakase, Yusuke Konishi, Masashi Ueda, Hideo Saji, Shiroh Futaki

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

We investigated the biodistribution of arginine-rich cell-penetrating peptides (CPPs) in tumor-xenografted nude mice after intravenous injection of fluorescently labeled CPPs using in vivo imaging. The CPPs used included HIV-1 Tat (48-60), penetratin, and the l- and d-enantiomers of oligoarginines (8, 12, and 16 residues), all of which are reported to have high cell penetration. Among the tested peptides, high accumulation in tumors was observed for the D-form of octaarginine (r8), and glycosaminoglycans played a key role. Injection of an r8-doxorubicin conjugate (4 mg doxorubicin/kg) effectively suppressed tumor proliferation, with no significant decrease in mouse weight, whereas administration of doxorubicin itself (6 mg/kg), yielding a similar degree of tumor-growth suppression, resulted in significant weight loss. These results suggest the potential of r8 as a prototypic tumor-targeting vector.

Original languageEnglish
Pages (from-to)181-188
Number of pages8
JournalJournal of Controlled Release
Volume159
Issue number2
DOIs
Publication statusPublished - Apr 30 2012
Externally publishedYes

Fingerprint

Cell-Penetrating Peptides
Arginine
Doxorubicin
Pharmaceutical Preparations
Neoplasms
Glycosaminoglycans
Nude Mice
Intravenous Injections
Weight Loss
Weights and Measures
Peptides
Injections
Growth

Keywords

  • Arginine-rich cell-penetrating peptide
  • Biodistribution
  • Doxorubicin
  • Drug delivery
  • In vivo fluorescent imaging
  • Tumor accumulation

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo. / Nakase, Ikuhiko; Konishi, Yusuke; Ueda, Masashi; Saji, Hideo; Futaki, Shiroh.

In: Journal of Controlled Release, Vol. 159, No. 2, 30.04.2012, p. 181-188.

Research output: Contribution to journalArticle

Nakase, Ikuhiko ; Konishi, Yusuke ; Ueda, Masashi ; Saji, Hideo ; Futaki, Shiroh. / Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo. In: Journal of Controlled Release. 2012 ; Vol. 159, No. 2. pp. 181-188.
@article{c5e78c9923524e0f928ffb9e5c7a075d,
title = "Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo",
abstract = "We investigated the biodistribution of arginine-rich cell-penetrating peptides (CPPs) in tumor-xenografted nude mice after intravenous injection of fluorescently labeled CPPs using in vivo imaging. The CPPs used included HIV-1 Tat (48-60), penetratin, and the l- and d-enantiomers of oligoarginines (8, 12, and 16 residues), all of which are reported to have high cell penetration. Among the tested peptides, high accumulation in tumors was observed for the D-form of octaarginine (r8), and glycosaminoglycans played a key role. Injection of an r8-doxorubicin conjugate (4 mg doxorubicin/kg) effectively suppressed tumor proliferation, with no significant decrease in mouse weight, whereas administration of doxorubicin itself (6 mg/kg), yielding a similar degree of tumor-growth suppression, resulted in significant weight loss. These results suggest the potential of r8 as a prototypic tumor-targeting vector.",
keywords = "Arginine-rich cell-penetrating peptide, Biodistribution, Doxorubicin, Drug delivery, In vivo fluorescent imaging, Tumor accumulation",
author = "Ikuhiko Nakase and Yusuke Konishi and Masashi Ueda and Hideo Saji and Shiroh Futaki",
year = "2012",
month = "4",
day = "30",
doi = "10.1016/j.jconrel.2012.01.016",
language = "English",
volume = "159",
pages = "181--188",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo

AU - Nakase, Ikuhiko

AU - Konishi, Yusuke

AU - Ueda, Masashi

AU - Saji, Hideo

AU - Futaki, Shiroh

PY - 2012/4/30

Y1 - 2012/4/30

N2 - We investigated the biodistribution of arginine-rich cell-penetrating peptides (CPPs) in tumor-xenografted nude mice after intravenous injection of fluorescently labeled CPPs using in vivo imaging. The CPPs used included HIV-1 Tat (48-60), penetratin, and the l- and d-enantiomers of oligoarginines (8, 12, and 16 residues), all of which are reported to have high cell penetration. Among the tested peptides, high accumulation in tumors was observed for the D-form of octaarginine (r8), and glycosaminoglycans played a key role. Injection of an r8-doxorubicin conjugate (4 mg doxorubicin/kg) effectively suppressed tumor proliferation, with no significant decrease in mouse weight, whereas administration of doxorubicin itself (6 mg/kg), yielding a similar degree of tumor-growth suppression, resulted in significant weight loss. These results suggest the potential of r8 as a prototypic tumor-targeting vector.

AB - We investigated the biodistribution of arginine-rich cell-penetrating peptides (CPPs) in tumor-xenografted nude mice after intravenous injection of fluorescently labeled CPPs using in vivo imaging. The CPPs used included HIV-1 Tat (48-60), penetratin, and the l- and d-enantiomers of oligoarginines (8, 12, and 16 residues), all of which are reported to have high cell penetration. Among the tested peptides, high accumulation in tumors was observed for the D-form of octaarginine (r8), and glycosaminoglycans played a key role. Injection of an r8-doxorubicin conjugate (4 mg doxorubicin/kg) effectively suppressed tumor proliferation, with no significant decrease in mouse weight, whereas administration of doxorubicin itself (6 mg/kg), yielding a similar degree of tumor-growth suppression, resulted in significant weight loss. These results suggest the potential of r8 as a prototypic tumor-targeting vector.

KW - Arginine-rich cell-penetrating peptide

KW - Biodistribution

KW - Doxorubicin

KW - Drug delivery

KW - In vivo fluorescent imaging

KW - Tumor accumulation

UR - http://www.scopus.com/inward/record.url?scp=84861057424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861057424&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2012.01.016

DO - 10.1016/j.jconrel.2012.01.016

M3 - Article

VL - 159

SP - 181

EP - 188

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 2

ER -